ADAPTIN BIO, INC.
OTC · CIK 0001938571 · Fiscal year end 1231
Latest reported period: Latest published period
Operating Income
$-1.1M
Net Income
$-1.1M
Eps Basic
-0.13
Recent financials
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-1.1M | - | - |
| Net Income | $-1.1M | - | - |
| Eps Basic | -0.13 | - | - |
| Eps Diluted | -0.13 | - | - |
| Cash And Equivalents | $301,309 | - | - |
| Total Assets | $706,117 | - | - |
| Total Liabilities | $2.5M | - | - |
| Shareholders Equity | $-1.8M | - | - |
| Operating Cash Flow | $-596,298 | - | - |
Latest filings
| Form | Company | Filed | Accession |
|---|---|---|---|
| POS AM | ADAPTIN BIO, INC. | 2026-07-21 | 0001213900-26-080096 |
| 10-Q | ADAPTIN BIO, INC. | 2026-05-15 | 0001213900-26-057188 |
| 10-K | ADAPTIN BIO, INC. | 2026-04-01 | 0001213900-26-038568 |
| 10-Q | ADAPTIN BIO, INC. | 2025-11-14 | 0001213900-25-110559 |
| 10-Q | ADAPTIN BIO, INC. | 2025-08-14 | 0001213900-25-076361 |